<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">702819</article-id><article-id pub-id-type="doi">10.17816/dv702819</article-id><article-id pub-id-type="edn">LLYAQE</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DERMATOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДЕРМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Autoimmune progesterone dermatitis: difficulties in diagnosis and choice of treatment method based on the example of clinical cases</article-title><trans-title-group xml:lang="ru"><trans-title>Аутоиммунный прогестероновый дерматит: трудности диагностики и выбора метода терапии на примере клинических случаев</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7968-7663</contrib-id><contrib-id contrib-id-type="spin">3785-7859</contrib-id><name-alternatives><name xml:lang="en"><surname>Snarskaya</surname><given-names>Elena S.</given-names></name><name xml:lang="ru"><surname>Снарская</surname><given-names>Елена Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>snarskaya-dok@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0428-5627</contrib-id><contrib-id contrib-id-type="spin">5983-9344</contrib-id><name-alternatives><name xml:lang="en"><surname>Teplyakova</surname><given-names>Kseniya S.</given-names></name><name xml:lang="ru"><surname>Теплякова</surname><given-names>Ксения Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p>
<p> </p></bio><bio xml:lang="ru"><p>канд. мед. наук</p>
<p> </p></bio><email>hvpvea@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-3238-6517</contrib-id><name-alternatives><name xml:lang="en"><surname>Khrushcheva</surname><given-names>Anastasia V.</given-names></name><name xml:lang="ru"><surname>Хрущева</surname><given-names>Анастасия Валерьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>Dr.Khr.A@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">The First Sechenov Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-06-03" publication-format="electronic"><day>03</day><month>06</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-07-03" publication-format="electronic"><day>03</day><month>07</month><year>2026</year></pub-date><volume>29</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>272</fpage><lpage>281</lpage><history><date date-type="received" iso-8601-date="2026-02-16"><day>16</day><month>02</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-04-06"><day>06</day><month>04</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Эко-Вектор</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2029-07-03"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://eco-vector.com/for_authors.php#07</ali:license_ref></license></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/702819">https://rjsvd.com/1560-9588/article/view/702819</self-uri><abstract xml:lang="en"><p>Autoimmune progesterone dermatitis is an orphan disease characterized by the development of a cyclic polymorphic allergic skin reaction to endogenous and exogenous progesterone in women of reproductive age. The clinical picture of the dermatosis is characterized by significant variability of clinical manifestations, and insufficient awareness of specialists and the lack of standard diagnostic tests lead to diagnostic errors, ineffective therapy, and a significant decrease in the quality of life of patients.</p> <p>The article provides an overview of current data on the etiopathogenesis, clinical polymorphism, and diagnostic challenges of autoimmune progesterone dermatitis. It discusses various types of immune reactions (I, III, and IV) underlying the disease, analyzes the limitations of existing diagnostic methods, including intradermal tests, and highlights the potential of using enzyme-linked immunosorbent assay and ultrasound-assisted immune complex dissociation. The article also focuses on therapeutic approaches, from ovulation suppression to the use of targeted therapy and desensitization methods to preserve reproductive function.</p> <p>The article describes two clinical cases in patients aged 40 and 38 with a long history of the disease (2.5 and 10 years, respectively), resistance to standard therapy, and erroneous initial diagnoses. The combination of a characteristic clinical history (cyclic rashes during the luteal phase of the menstrual cycle) and a positive result of the progesterone resistance test using the method of ultrasound-assisted immune complex dissociation allowed for the diagnosis of autoimmune progesterone dermatitis, and the patients were subsequently referred to a specialized allergy center for the selection of pathogenetic therapy.</p> <p>The complexity of diagnosing autoimmune progesterone dermatitis is also associated with the need for differential diagnosis with a range of diseases, such as systemic lupus erythematosus, rheumatoid arthritis, psoriasis, Behçet disease, and others, that may worsen before the onset of the menstrual cycle. Multidisciplinary collaboration between dermatologists, allergists, and gynecologists is crucial for timely diagnosis and selection of the optimal pathogenetic therapy strategy, which can improve the prognosis of the disease and the quality of life of patients.</p> <p> </p></abstract><trans-abstract xml:lang="ru"><p>Аутоиммунный прогестероновый дерматит представляет собой редкое орфанное заболевание, характеризующееся развитием у женщин репродуктивного возраста циклической полиморфной аллергической реакции кожи на эндогенный и экзогенный прогестерон. Клиническая картина дерматоза отличается значительной вариабельностью клинических проявлений, а недостаточная осведомлённость специалистов и отсутствие стандартных диагностических тестов приводит к диагностическим ошибкам, неэффективности терапии и значительному снижению качества жизни пациентов.</p> <p>В статье представлен обзор современных данных об этиопатогенезе, клиническом полиморфизме и диагностических сложностях аутоиммунного прогестеронового дерматита. Рассматриваются различные типы иммунных реакций (I, III и IV), лежащие в основе заболевания, анализируются ограничения существующих методов диагностики, включая внутрикожные пробы, и перспективы использования иммуноферментного анализа и ультразвуковой диссоциации иммунных комплексов. Особое внимание уделено терапевтическим подходам: от подавления овуляции до применения таргетной терапии и методов десенсибилизации, позволяющих сохранить репродуктивную функцию.</p> <p>В работе описаны два клинических случая у пациенток 40 и 38 лет с длительным анамнезом заболевания (2,5 и 10 лет соответственно), резистентностью к стандартной терапии и ошибочным первичным диагнозом. Сочетание характерного клинического анамнеза (циклические высыпания в лютеиновую фазу менструального цикла) и положительного результата теста на резистентность к прогестерону с использованием метода ультразвуковой диссоциации иммунных комплексов позволило установить диагноз аутоиммунного прогестеронового дерматита, в связи с чем пациентки были направлены в специализированный центр аллергологии для подбора патогенетической терапии.</p> <p>Сложность диагностики аутоиммунного прогестеронового дерматита связана также с необходимостью проведения дифференциальной диагностики с целым рядом заболеваний, таких как системная красная волчанка, ревматоидный артрит, псориаз, болезнь Бехчета и другие, которые могут обостряться перед началом менструального цикла. Важным аспектом является мультидисциплинарное взаимодействие дерматологов, аллергологов и гинекологов, позволяющее не только своевременно верифицировать диагноз, но и выбрать оптимальную стратегию патогенетической терапии, что позволит улучшить прогноз заболевания и качество жизни пациенток.</p> <p> </p></trans-abstract><kwd-group xml:lang="en"><kwd>autoimmune progesterone dermatitis</kwd><kwd>clinical pattern</kwd><kwd>diagnosis</kwd><kwd>treatment</kwd><kwd>clinical cases</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аутоиммунный прогестероновый дерматит</kwd><kwd>клиническая картина</kwd><kwd>диагностика</kwd><kwd>лечение</kwd><kwd>клинические случаи</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Herzberg AJ, Strohmeyer CR, Cirillo-Hyland VA. Autoimmune progesterone dermatitis. J Am Acad Dermatol. 1995;32(2 Pt 2):333–338. doi: 10.1016/0190-9622(95)90398-4</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Steuer AB, Scherl S, Ashinoff R. Autoimmune progesterone dermatitis: a diagnosis to consider in a patient with cyclical cutaneous eruptions. J Drugs Dermatol. 2017;16(10):1040–1042.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Irshad S, Haider MS, Master MF, et al. Autoimmune progesterone dermatitis. Cureus. 2021;13(11):e19217. doi: 10.7759/cureus.19217 EDN: GZHEZN</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Farah FS, Shbaklu Z. Autoimmune progesterone urticaria. J Allergy Clin Immunol. 1971;48(5):257–261. doi: 10.1016/0091-6749(71)90025-x</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Whitt W, Stiegler J, Richardson C. Autoimmune progesterone dermatitis mimicking facial erythromelalgia successfully treated with hysterectomy and bilateral salpingo-oophrectomy. JAAD Case Rep. 2020;6(10):1104–1106. doi: 10.1016/j.jdcr.2020.08.026 EDN: FEOJJD</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Banwaith T, Acharya J. Autoimmune progesterone dermatitis mimicking eczematous dermatitis. Br J Hosp Med (Lond). 2022;83(2):1–4. doi: 10.12968/hmed.2021.0384</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Ghosh D, Bernstein JA. Development of a progesterone-specific IgE assay for diagnosing patients with suspected progestogen hypersensitivity. Ann Allergy Asthma Immunol. 2019;122(6):616–622. doi: 10.1016/j.anai.2019.03.032</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Chiarella SE, Buchheit KM, Foer D. Progestogen hypersensitivity. J Allergy Clin Immunol Pract. 2023;11(12):3606–3613.e2. doi: 10.1016/j.jaip.2023.07.050 EDN: FQKVUN</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Drayer SM, Laufer LR, Farrell ME. Autoimmune progesterone dermatitis mistaken for Stevens-Johnson syndrome. Obstet Gynecol. 2018;131(4):723–726. doi: 10.1097/AOG.0000000000002537</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Cheesman KL, Gaynor LV, Chatterton RT, Radvany RM. Identification of a 17-hydroxyprogesterone-binding immunoglobulin in the serum of a woman with periodic rashes. J Clin Endocrinol Metab. 1982;55(3):597–599. doi: 10.1210/jcem-55-3-597</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Baptist AP, Baldwin JL. Autoimmune progesterone dermatitis in a patient with endometriosis: case report and review of the literature. Clin Mol Allergy. 2004;2(1):10. doi: 10.1186/1476-7961-2-10 EDN: QAXDEQ</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Zachary C, Fackler N, Juhasz M, et al. Catamenial dermatoses associated with autoimmune, inflammatory, and systemic diseases: a systematic review. Int J Womens Dermatol. 2019;5(5):361–367. doi: 10.1016/j.ijwd.2019.09.008</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Aghazadeh N, Berry NA, Torgerson RR, et al. Autoimmune progesterone dermatitis: a retrospective case series. Int J Womens Dermatol. 2022;8(3):e009. doi: 10.1097/JW9.0000000000000009 EDN: VJRZWV</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Solomon M, Itsekson AM, Lev-Sagie A. Autoimmune progesterone dermatitis. Curr Dermatol Rep. 2013;2(4):258–263. doi: 10.1007/s13671-013-0059-5</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Foer D, Tran LK, Wickner P, et al. Challenges in skin testing for progestogen hypersensitivity. Ann Allergy Asthma Immunol. 2021;126(1):100–102. doi: 10.1016/j.anai.2020.09.002 EDN: CMJEUJ</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Patent RUS RU2022115595A. Pastushenkov VL, Bezhenar VF, Molchanov OL, et al. A method for diagnosing progesterone resistance. (In Russ.) Available at: https://patents.google.com/patent/RU2022115595A/ru Accessed: 2026 Feb 15.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Özdemir Ö, Yahşi GG, Atalay CR. Autoimmune progesterone dermatitis: a case report. Rev Bras Ginecol Obstet. 2019;41(3):203–205. doi: 10.1055/s-0039-1678589</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Zhang M, Tang X, Zhou H, et al. Case of autoimmune progesterone dermatitis presenting as necrotic migratory erythema successfully controlled by danazol. J Dermatol. 2020;47(2):178–180. doi: 10.1111/1346-8138.15180</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Brestel EP, Thrush LB. The treatment of glucocorticosteroid-dependent chronic urticaria with stanozolol. J Allergy Clin Immunol. 1988;82(2):265–269. doi: 10.1016/0091-6749(88)91010-x</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Heffler E, Fichera S, Nicolosi G, Crimi N. Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab. J Allergy Clin Immunol Pract. 2017;5(3):852–854. doi: 10.1016/j.jaip.2017.01.003</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Aghazadeh N, Chattha AJ, Hartz MF, Davis DM. Autoimmune progesterone dermatitis in the adolescent population. Pediatr Dermatol. 2021;38(2):380–384. doi: 10.1111/pde.14423 EDN: ECJUFA</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Sandru F, Dumitrascu MC, Petca A, et al. Progesterone hypersensitivity in assisted reproductive technologies: implications for safety and efficacy. J Pers Med. 2024;14(1):79. doi: 10.3390/jpm14010079 EDN: WMAKER</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Foer D, Buchheit KM, Gargiulo AR, et al. Progestogen hypersensitivity in 24 cases: diagnosis, management, and proposed renaming and classification. J Allergy Clin Immunol Pract. 2016;4(4):723–729. doi: 10.1016/j.jaip.2016.03.003</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Maciejewska-Jeske M, Szeliga A, Męczekalski B. Consequences of premature ovarian insufficiency on women’s sexual health. Prz Menopauzalny. 2018;17(3):127–130. doi: 10.5114/pm.2018.78557</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Shamad M, Ibrahim NO, AlMutairi N. Exploring the relationship between menstrual cycle and urticaria: insights from a cross-sectional study. Asia Pac Allergy. 2025;15(3):204–207. doi: 10.5415/apallergy.0000000000000206 EDN: UJCFFG</mixed-citation></ref></ref-list></back></article>
